James Brooke Murray

This inventor holds 30 USPTO granted patents and 12 published patent applications, plus 16 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Les Laboratoires Servier, Vernalis &r&d) Ltd., Les Laboratories Servier. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Brooke Murray. Retrieved from https://idiyas.com/inventor/james-brooke-murray

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 30 (Patent Applications = 12)

% Patents Active = 93.3

CIPO Patents = 16 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 23)

Average Co-Inventor Count = 13.1

ph-index = 4

Forward Citations = 43(Granted Patents)

Company Filing History:

27 out of 296

Les Laboratoires Servier

Les Laboratories Servier

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Pro-Apoptotic Agents

Piperidine Derivatives

Pyrrole Compounds

BCL-XL Inhibitors

Isoindoline Compounds

Indole Compounds

Thienopyrimidine Derivatives

Aminoacid Derivatives

Hydroxyester Derivatives

Indolizine Compounds

Hydroxyacid Derivatives

Phosphate Compounds

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649733 - 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS (2026-06-09),

2. 12570648 - 6,7-DIHYDRO-5H-PYRIDO[2,3-C]PYRIDAZINE DERIVATIVES AND RELATED COMPOUNDS AS BCL-XL PROTEIN INHIBITORS AND PRO-APOPTOTIC AGENTS FOR TREATING CANCER (2026-03-10),

3. 11332472 - Substituted piperidines as inhibitors of ubiquitin specific protease 7 (2022-05-17),

4. 11058689 - Pyrrole compounds, a process for their preparation and pharmaceutical (2021-07-13),

5. 11046681 - Substituted piperidines for the treatment of cancer (2021-06-29),

6. 11028070 - Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them (2021-06-08),

7. 10711010 - Hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them (2020-07-14),

8. 10689364 - Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them (2020-06-23),

9. 10688101 - Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them (2020-06-23),

10. 10662173 - Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them (2020-05-26),

11. 10654849 - (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them (2020-05-19),

12. 10618909 - Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them (2020-04-14),

13. 10457687 - Aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them (2019-10-29),

14. 10414754 - Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them (2019-09-17),

15. 10323041 - Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them (2019-06-18),

Title: Unveiling the Inventive Genius of James Brooke Murray

Introduction: James Brooke Murray, a talented inventor hailing from Linton, GB, has made significant contributions in the field of pharmaceuticals with an impressive portfolio of 28 patents.

Latest Patents: Among his latest patents, James Brooke Murray has innovated in areas such as "Substituted piperidines as inhibitors of ubiquitin specific protease 7" and "Pyrrole compounds for treating pathologies involving a deficit in apoptosis". These inventions showcase his dedication to advancing the realm of medicinal products for diseases like cancer and auto-immune conditions.

Career Highlights: James Brooke Murray has showcased his pioneering spirit through his work with esteemed companies like Vernalis (R&D) Limited and Les Laboratoires Servier. His expertise and innovative approach have undoubtedly left a lasting impact on the pharmaceutical industry.

Collaborations: Throughout his career, James Brooke Murray has collaborated with industry experts such as Olivier Geneste and James Edward Paul Davidson. These partnerships have likely been instrumental in fostering creativity and driving forward groundbreaking innovations.

Conclusion: James Brooke Murray's relentless pursuit of innovation and his remarkable patent portfolio exemplify his unwavering commitment to advancing pharmaceutical research. His contributions continue to inspire new generations of inventors in the quest for cutting-edge solutions to complex medical challenges.

Profile summary based on public USPTO records.